<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr virus (EBV) is associated with a number of different human <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> and appears to play different pathogenetic roles in each case </plain></SENT>
<SENT sid="1" pm="."><plain>Thus, <z:e sem="disease" ids="C1521815" disease_type="Neoplastic Process" abbrv="">immunoblastic</z:e> B cell <z:hpo ids='HP_0002665'>lymphomas</z:hpo> of the immunosuppressed display the full pattern of EBV latent gene expression (expressing Epstein-Barr nuclear antigen [EBNA]1, 2, 3A, 3B, 3C, and -LP, and latent membrane protein [LMP]1, 2A, and 2B), just as do B lymphoblastoid cell lines transformed by the virus in vitro </plain></SENT>
<SENT sid="2" pm="."><plain>In contrast, those EBV-associated <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> with a more complex, multistep pathogenesis show more restricted patterns of <z:mp ids='MP_0001799'>viral</z:mp> gene expression, limited in Burkitt's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> to EBNA1 only and in nasopharyngeal <z:mp ids='MP_0002038'>carcinoma</z:mp> (NPC) to EBNA1 and LMP1, 2A, and 2B </plain></SENT>
<SENT sid="3" pm="."><plain>Recent evidence has implicated EBV in the pathogenesis of another <z:mp ids='MP_0002022'>lymphoid tumor</z:mp>, <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e>), where the malignant Hodgkin's and Reed-Sternberg (HRS) cells are EBV genome positive in up to 50% of cases </plain></SENT>
<SENT sid="4" pm="."><plain>Here we extend preliminary results on <z:mp ids='MP_0001799'>viral</z:mp> gene expression in HRS cells by adopting polymerase chain reaction-based and in situ hybridization assays capable of detecting specific EBV latent transcripts diagnostic of the different possible forms of EBV latency </plain></SENT>
<SENT sid="5" pm="."><plain>We show that the transcriptional program of the virus in HRS cells is similar to that seen in NPC in several respects: (a) selective expression of EBNA1 <z:chebi fb="2" ids="33699">mRNA</z:chebi> from the BamHI F promoter; (b) downregulation of the BamHI C and W promoters and their associated EBNA <z:chebi fb="2" ids="33699">mRNAs</z:chebi>; (c) expression of LMP1 and, in most cases, LMP2A and 2B transcripts; and (d) expression of the "rightward-running" BamHI A transcripts once thought to be unique to NPC </plain></SENT>
<SENT sid="6" pm="."><plain>This form of latency, consistently detected in EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> irrespective of histological subtype, implies an active role for the virus in the pathogenesis of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">HD</z:e> and also suggests that the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> may remain sensitive to at least certain facets of the EBV-induced cytotoxic T cell response </plain></SENT>
</text></document>